Are you in pain? In some cases, exercising may be as good as painkillers

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-27T13:49:52.686Z • Permanent link

Pioneering researchers at the University of California, Los Angeles (UCLA) have made a groundbreaking discovery that challenges conventional wisdom on pain management. Led by renowned scientist Dr. Jeffrey Rabkin, the team conducted a rigorous study involving over 3,000 participants from the United States, the United Kingdom, and Australia. The results, published in the Journal of Pain Research, reveal that even modest amounts of exercise can alleviate pain as effectively as common painkillers. The study's findings have significant implications for the pharmaceutical industry, which has long relied on pain medications to treat chronic pain conditions.

Dr. Rabkin's team designed a 12-week exercise program that combined elements of yoga, tai chi, and Pilates. Participants were randomly assigned to either the exercise group or a control group, which received standard pain medication. The researchers monitored participants' pain levels, physical function, and quality of life before and after the intervention. The results showed that the exercise group experienced significant reductions in pain, improved physical function, and enhanced quality of life. Notably, the exercise group also demonstrated comparable pain relief to the control group, which received standard pain medication.

The study's findings have sparked excitement among researchers and clinicians, who are eager to explore the therapeutic potential of exercise-based interventions for pain management. Dr. Rabkin's team is now working to develop personalized exercise programs that can be tailored to individual patients' needs. The UCLA researchers are also collaborating with industry partners to translate their findings into practical applications. With the global pain management market projected to reach $45.8 billion by 2025, the study's results could have far-reaching implications for the development of new treatments and therapies.

Exercising may be as good as painkillers for some people, opening up new possibilities for holistic therapeutic approaches. Companies like Pfizer and Johnson & Johnson, which dominate the pain management market, may need to rethink their strategies in light of these findings. Researchers at the University of California, Los Angeles (UCLA), have made a groundbreaking discovery that challenges conventional wisdom on pain management. The study's results have significant implications for the pharmaceutical industry, which has long relied on pain medications to treat chronic pain conditions.

The study's findings also have implications for healthcare systems, which may need to invest in exercise-based interventions as a complementary treatment for pain management. The UK's National Health Service (NHS), for example, has already begun to incorporate exercise programs into its treatment protocols for chronic pain conditions. As the global healthcare market continues to shift towards more preventive and holistic approaches, companies like Fitbit and Apple may see increased demand for exercise-based interventions.

The discovery of exercise-based pain relief is part of a larger trend towards personalized medicine and precision health. With the advent of genomics and precision diagnostics, healthcare providers are increasingly able to tailor treatment protocols to individual patients' needs. This approach has led to significant advances in cancer treatment, cardiovascular disease management, and mental health care.